BioSpace News Archive

Sun Genomics, the direct-to-consumer custom probiotics and gut health company, announced today $8.65 million in Series A funding.

Abbott (NYSE: ABT) and Tandem Diabetes Care (NASDAQ: TNDM) announced today that they have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott’s world-leading1 continuous glucose monitoring (CGM) technology with Tandem’s innovative insulin delivery systems to provide more options for people to manage their diabetes.

Eurofins DiscoverX, the products company of Eurofins Discovery, today announced the expansion of their CRO Certification Program for Bioassays with Catalent Biologics as a North American provider c

Castlight Health, Inc. (NYSE: CSLT) today announced the availability of its behavioral health solution to help employees easily access and navigate behavioral health support and resources amidst the COVID-19 pandemic

Echosens , a high-technology company offering the FibroScan family of products, today announces the release of its white paper authored by Dr. Reed Hogan, M.D., GI Associates (GIA) in Flowood, Mississippi, “ Understanding the Many Benefits of Comprehensive, Chronic Care Management (CCM) of Liver Dis

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its second quarter 2020 results on Wednesday, July 29, 2020 at 12 p.m. London time (7 a.m. Eastern Daylight Time). The Company will release its second quarter 2020 results prior to the call. A live audiocast of the conference call will be available on the Investor Relations section of the LivaNova we

First dosing of Tacrolimus Inhalation Powder initiates development program for direct-to-lung delivery of a Thin Film Freezing dry-powder product for prevention of lung transplant rejection Phase 1 topline data indicates safety of single doses of Voriconazole Inhalation Powder up to 80 mg/dose in healthy subjects for direct-to-lung delivery of voriconazole for Invasive Pulmonary Aspergillosis AUSTIN, Texas--( BUSINESS WIRE )-- TFF Pharmaceutic

- Live on-air interview to feature Citius CEO on Tuesday, June 30th at 1:20pm ET - CEO to discuss potential use of Induced Mesenchymal Stem Cells (iMSCs) for the treatment of acute respiratory distress syndrome (ARDS) in patients with COVID-19 - Company to provide update about ongoing Phase 3 FDA Trial for Mino-Lok® [29-June-2020] CRANFORD, N.J. , J

Turret Capital Management, a global venture building and investment firm focused on the healthcare industry, has signed a Definitive License Agreement with Or-Genix Therapeutics, Inc. Under the terms of the agreement, Turret Capital has obtained global co-development rights for a family of breakthrough, topically-acting, proprietary small m

Synergy Laboratories (Synergy) announced today that it is now able to test for the presence of key antibodies to the coronavirus. Individuals infected with the coronavirus produce IgM and IgG antibodies and identifying these antibodies can play a crucial role in understanding the degree of immunity a COVID-19 survivor has developed. Brad Pitts , Synergy’s Chief Executive Officer said, “Once we can determine the leve